That said, the full picture is more nuanced than a simple yes or no
however, the availability of compounded semaglutide and compounded tirzepatide is listed as not confirmed in the directory data provided
Postanowienie dotyczy wszystkich serii preparatu: Trulicity, Dulaglutidum, 0,75 mg, roztwr do wstrzykiwa, 2 wstrzykiwacze po 0,5 ml, GTIN: 05909991219130, Trulicity, Dulaglutidum, 1,5 mg, roztwr do wstrzykiwa, 2 wstrzykiwacze po 0,5 ml, GTIN: 05909991219161, Trulicity, Dulaglutidum, 3 mg, roztwr do wstrzykiwa, 2 wstrzykiwacze po 0,5 ml, GTIN: 08594012697638, Trulicity, Dulaglutidum, 4,5 mg, roztwr do wstrzykiwa, 2 wstrzykiwacze po 0,5 ml, GTIN: 08594012697645
We are now responsible for bringing this molecule to market, while Adalvo owns the technology and is responsible for developing and manufacturing the molecule, said Isabella Wanderley, president of Sandozs Brazilian subsidiary and a former general manager at Novo Nordisk
Rohner was swept up in the conversation as well